Patients who have been receiving compounded semaglutide through Hims should ask directly about the current pharmacy fulfilling their prescription and its regulatory status, particularly given the platforms transition toward branded medications following the March 2026 Novo Nordisk deal
Nausea, constipation, and reduced appetite are common but typically temporary
Eur J Endocrinol (2013) 169(5):71523
Ideal candidates for semaglutide include: Adults with type 2 diabetes (Ozempic and Rybelsus) Adults who have established heart and blood vessel-related disease or those who are at risk of developing these diseases or heart failure (Ozempic) Adults with chronic kidney disease and type 2 diabetes, to reduce the risk of worsening kidney disease or end-stage renal disease (Ozempic) Children aged 12 or more, adolescents, and adults with obesity (BMI 30 or more) and overweight (BMI 27 or more) with at least one weight-related complication, such as hypercholesterolemia, hyperlipidemia, heart disease, and hypertension (Wegovy) Patients with metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver scarring or fibrosis, but they should not have cirrhosis (Wegovy) Head-to-head comparison: Metformin vs
Drinking at least 8 glasses of water daily supports kidney function and helps prevent constipation, a common early side effect
Research groups examine molecular stability and structural characteristics under laboratory conditions
